Abstract
The cell cycle is composed of a series of steps which can be negatively or postively regulated by various factors. Chief among the negative regulators is the p53 protein. Alteration or inactivation of p53 by mutation, or by its interactions with oncogene products of DNA tumour viruses, can lead to cancer. These mutations seem to be the most common genetic change in human cancers.
Similar content being viewed by others
References
Linzer, D. I. H. & Levine, A. J. Cell 17, 43–52 (1979).
Lane, D. P. & Crawford, L. V. Nature 278, 261–263 (1979).
DeLeo, A. B. et al. Proc. natn. Acad. Sci. U.S.A. 76, 2420–2424 (1979).
Linzer, D. I. H., Maltzman, W. & Levine, A. J., Virology 98, 308–318 (1979).
Oren, M., Maltzmann, W. & Levine, A. J. Molec. cell. Biol. 1, 101–110 (1981).
Reich, N. C., Oren, M. & Levine, A. J. Molec. cell. Biol. 3, 2143–2150 (1983).
Jenkins, J. R., Rudge, K. & Currie, G. A. Nature 312, 651–654 (1984).
Eliyahu, D., Raz, A., Gruss, P., Givol, D. & Oren, M. Nature 312, 646–649 (1984).
Parada, L. F., Land, H., Weinberg, R. A., Wolf, D. & Rotter, V. Nature 312, 649–651 (1984).
Hinds, P. W., Finlay, C. A. & Levine, A. J. J. Virol. 63, 739–746 (1989).
Finlay, C. A., Hinds, P. W. & Levine, A. J. Cell 57, 1083–1093 (1989).
Eliyahu, D., Michalovltz, D., Eliyahu, S., Pinhasi-Kimhi, O. & Oren, M. Proc. natn. Acad. Sci. U.S.A. 86, 8763–8767 (1989).
Mercer, W. F. et al. J. Cell Biochem. 14, 285–290 (1990).
Baker, S. J., Markowitz, S., Fearon, E. R., Wilson, J. K. U. & Vogelstein, B. Science 249, 912–915 (1990).
Diller, L. et al. Molec. cell. Blol. 10, 5772–5781 (1990).
Michalovitz, D., Halevy, O. & Oren, M. Cell 62, 671–680 (1990).
Martinez, J., Georgoff, I., Martinez, J. & Levine, A. J. Genes Dev. 5, 151–159 (1991).
Chen, P.-L., Chen, Y., Bookstein, R. & Lee, W.-H. Science 250, 1576–1580 (1990).
Mowat, M. A., Cheng, A., Kimura, N., Bernstein, A. & Benchimol, S. Nature 314, 633–636 (1985).
Baker, S. J. et al. Science 244, 217–221 (1989).
Nigro, J. M. et al. Nature 342, 705–708 (1989).
Vogelstein, B. Nature 348, 681–682 (1990).
Takahashi, T. et al. Science 246, 491–494 (1989).
Iggo, R., Gatter, K., Bartek, J., Lane, D. & Harris, A. L. Lancet 335, 675–679 (1990).
James, C. D., Carlbom, E., Nordenskjold, M., Collins, V. P. & Cavanee, W. K. Proc. natn. Acad. Sci. U.S.A. 86, 2858–2862 (1989).
Mackay, J., Steel, C. M., Elder, P. A., Forrest, A. P. M. & Evans, H. J. Lancet, ii, 1384–1385 (1988).
Kelman, Z. et al. Blood 74, 2318–2324 (1989).
Soussi, T., Caron de Fromental, C. & May, P. Oncogene 5, 945–952 (1990).
Malkin, D. et al. Science 250, 1233–1238 (1990).
Lavigueur, A. et al. Molec. cell. Biol. 9, 3982–3991 (1989).
Hinds, P. W. et al. Cell Growth Different. 1, 571–580 (1990).
Halvey, O., Michalovitz, D. & Oren, M. Science 250, 113–116 (1990).
Yewdell, J., Gannon, J. V. & Lane, D. P. J. Virol. 59, 444–452 (1986).
Gannon, J. V., Greaves, R., Iggo, R. & Lane, D. P. EMBO J. 9, 1595–1602 (1990).
Raycroft, L., Wu, H. & Lozano, G. Science 249, 1049–1051 (1990).
Fields, S. & Jang, S. K. Science 249, 1046–1049 (1990).
Gannon, J. V. & Lane, D. P. Nature 349, 802–806 (1991).
Ginsberg, D., Michalovitz, D., Ginsberg, D. & Oren, M. Molec. cell. Biol. (in the press).
Labow, M. A., Baim, S. B., Shenk, T. & Levine, A. J. Molec. cell. Biol. 10, 3343–3356 (1990).
Wolf, D., Harris, N. & Rotter, V. Cell 38, 119–126 (1984).
Sarnow, P., Ho, Y. S., Williams, J. & Levine, A. J. Cell 28, 387–394 (1982).
Werness, B. A., Levine, A. J. & Howley, P. M. Science 248, 76–79 (1990).
Whyte, P. et al. Nature 334, 124–129 (1988).
DeCaprio, J. A. et al. Cell 54, 275–283 (1988).
Dyson, N., Howley, P. M., Munger, K. & Harlow, E. Science 243, 934–936 (1989).
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. Cell 63, 1129–1136 (1990).
Braithwaite, A. W. et al. Nature 329, 458–460 (1987).
Gannon, J. V. & Lane, D. P. Nature 329, 456–458 (1987).
Wang, E. H., Friedman, P. N. & Prives, C. Cell 57, 379–392 (1989).
Wilcock, D. & Lane, D. P. Nature 349, 429–432 (1991).
Kern, S. E. et al. Oncogene 6, 131–136 (1991).
Scheffner, M., Munger, K., Byrne, J. C. & Howley, P. M. Proc. natn. Acad. Sci. U.S.A. (in the press).
Baker, S. J. et al. Cancer Res. 50, 7717–7722 (1991).
Chiba, I. et al. Oncogene 5, 1603–1610 (1990).
Prosser, J., Thompson, A. M., Cranston, G. & Evans, H. J. Oncogene 5, 1573–1579 (1990).
Cheng, J. & Haas, M. Molec. cell. Biol. 10, 5502–5509 (1990).
Bartek, J., Iggo, R., Gannon, J. & Lane, D. Oncogene 5, 893–899 (1990).
Rodrigues, N. R. et al. Proc. natn. Acad. Sci. U.S.A. 87, 7555–7559 (1990).
Menon, A. C. et al. Proc. natn. Acad. Sci. U.S.A. 87, 5435–5439 (1990).
Mulligan, L. M., Matlashewski, G. J., Scrable, H. J. & Cavenee, W. K. Proc. natn. Acad. Sci. U.S.A. 87, 5863–5867 (1990).
Romano, J. W. et al. Oncogene 4, 1483–1488 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levine, A., Momand, J. & Finlay, C. The p53 tumour suppressor gene. Nature 351, 453–456 (1991). https://doi.org/10.1038/351453a0
Issue Date:
DOI: https://doi.org/10.1038/351453a0
- Springer Nature Limited
This article is cited by
-
Establishment of primary prostate epithelial and tumorigenic cell lines using a non-viral immortalization approach
Biological Research (2024)
-
P53 Overexpression May Represent an Early Marker of Clinicopathologic Progression in Vasculogenic Mesenchymal Lesions of Germ Cell Tumor Origin
Virchows Archiv (2024)
-
Cytogenotoxicity and inflammatory response in liver of rats exposed to different doses of cannabis nano emulsions
Archives of Toxicology (2024)
-
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Nature Reviews Drug Discovery (2023)
-
The correlation between P53 and COX-2 expression and the pathological alteration in hepatocellular carcinoma
Egyptian Journal of Medical Human Genetics (2022)